Sponsors and exhibitors


Bristol-Myers Squibb is a global biopharmaceutical company focused on discovering, developing and delivering innovative medicines for patients with serious diseases. Our people are focused on helping millions of patients around the world in disease areas such as oncology, cardiovascular, immunoscience and fibrosis. We have built a sustainable pipeline of potential therapies, and are leveraging translational medicine and data analytics to understand how we can deliver the right medicine to the right patient at the right time to achieve the best outcome. 

Through the Bristol-Myers Squibb Foundation, we promote health equity and seek to improve health outcomes of populations disproportionately affected by serious diseases and conditions, giving new hope to some of the world’s most vulnerable people. Each day, our employees around the world work together for patients – it drives everything we do.

Helsinn is a privately owned pharmaceutical group with an extensive portfolio of marketed cancer care products and a robust drug development pipeline. Since 1976, Helsinn has been improving the everyday lives of patients, guided by core family values of respect, integrity and quality. The Group works across pharmaceuticals, biotechnology, medical devices and nutritional supplements and has expertise in research, development, manufacture and the commercialization of therapeutic and supportive care products for cancer, pain and inflammation and gastroenterology. In 2016, Helsinn created the Helsinn Investment Fund to support early-stage investment opportunities in areas of unmet patient need. The company is headquartered in Lugano, Switzerland, with operating subsidiaries in Switzerland, Ireland, the U.S., Monaco and China, as well as a product presence in approximately 190 countries globally.


To learn more about Helsinn Group please visit  www.helsinn.com

For more than a century, MSD has been inventing for life, bringing forward medicines and vaccines for many of the world's most challenging diseases. Today, MSD continues be at the forefront of research to deliver innovative health solutions and advance the prevention and treatment of diseases that threaten people and animals around the world.


Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology.

Amgen focuses on areas of high unmet medical need and leverages its expertise to strive for solutions that improve health outcomes and dramatically improve people's lives. A biotechnology pioneer since 1980, Amgen has grown to be one of the world's leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential.


Novartis Oncology is a global leader in improving outcomes for people living with cancer and other diseases. We seek to transform cancer care through distinctive scientific and clinical strategies focused on developing targeted, immuno-oncology and combination therapies to create more effective options for patients. The company offers a wide range of innovative therapies to help meet patient needs and our oncology pipeline is one of the strongest and most productive in the industry. For more information about how we are helping to revolutionize the treatment of cancer and other diseases, please visit www.novartisoncology.com.

“Pierre Fabre Laboratories is a French multinational, privately-owned pharmaceutical and dermo-cosmetic company present in 130 countries.

Oncology is one of our priorities, with programs focusing particularly on targeted therapies, biotherapies and immuno-oncology.

We work in therapeutic areas of high unmet medical need, including onco-hematology and dermato-oncology (particularly skin tumors/melanoma).

Thanks to our experience in both innovation and manufacturing, we are now recognized as one of the leading global names in oncology,

in dermatology and in dermo-cosmetics with our international brand leader “Eau Thermale Avène”.


For more information, please visit www.pierre-fabre.com

Sanofi Genzyme, the specialty care global business unit of Sanofi, focuses on oncology, immunology, multiple sclerosis, and rare diseases.  Our approach is shaped by our experience developing highly specialized treatments and forging close relationships with physician and patient communities. We are dedicated to discovering and advancing new therapies, providing hope to patients and their families around the world.  Since 2015, Sanofi and Regeneron have been in a global collaboration agreement dedicated to pursuing a broad, ambitious and long-term vision for immuno-oncology.


For more information visit:




Roche is a global pioneer in pharmaceuticals and diagnostics focused on advancing science to improve people’s lives. The combined strengths of pharmaceuticals and diagnostics under one roof have made Roche the leader in personalised healthcare – a strategy that aims to fit the right treatment to each patient in the best way possible.


LEO Pharma helps people achieve healthy skin. By offering care solutions to patients in more than 130 countries globally, LEO Pharma supports people in managing their skin conditions. Founded in 1908 and owned by the LEO Foundation, the healthcare company has devoted decades of research and development to delivering products and solutions to people with skin conditions. LEO Pharma is headquartered in Denmark and employs around 5.000 people worldwide.


For more information visit www.leo-pharma.com


Immuno-oncology is a top priority for Merck and Pfizer. The alliance between Merck and Pfizer enables the companies to benefit from each other’s strengths and capabilities and further explore the therapeutic potential of avelumab, an anti-PD-L1 antibody initially discovered and developed by Merck. The alliance will jointly develop and commercialize avelumab and is striving to find new ways to treat cancer.


For more information visit:





Almirall is a leading skin-health focused global pharmaceutical company that partners with healthcare professionals, applying Science to provide medical solutions to patients & future generations. Our efforts are focused on fighting against skin health diseases and helping people feel and look their best. We support healthcare professionals in its continuous improvement, bringing our innovative solutions where they are needed.

The company, founded almost 75 years ago and with headquarters in Barcelona, is listed on the Spanish Stock Exchange (ticker: ALM). Almirall has become a key element of value creation to society according to its commitment with its major shareholders and its decision to help others, to understand their challenges and to use Science to provide them with solutions for real life. Total revenues in 2017 were 755.8 million euros. More than 1,830 employees are devoted to Science.

Altruist Dermatologist Sunscreen provides high quality dermatologist specification sun protection at the lowest possible price, by reducing profit margins, with the aim of reducing the incidence of skin cancer.

Altruist was created in 2015 by Dr Andrew Birnie, Consultant Dermatologist and Dermatological Surgeon in Canterbury, UK, and his friend David Westerbeek van Eerten a Dutch economist with a background in skin care. Feedback from dermatologists and their patients has been fantastic, and there are over 900 positive reviews on Amazon. It is now the number one online only suncare brand in the UK.

In addition to providing premium sun protection for everybody any profits are reinvested to create new products, on health promotion campaigns and given to charities supporting people with albinism in Africa.

It is available through amazon.co.uk (who deliver all over the world), plus amazon.es and amazon.it


For more information visit: https://www.altruistsun.com

Pierre Fabre Laboratories is a French multinational, privately-owned pharmaceutical and dermo-cosmetic company present in 130 countries. Oncology is one of our priorities, with programs focusing particularly on targeted therapies, biotherapies and immuno-oncology. We work in therapeutic areas of high unmet medical need, including onco-hematology and dermato-oncology (particularly skin tumors/melanoma).

Thanks to our experience in both innovation and manufacturing, we are now recognized as one of the leading global names in oncology, in dermatology and in dermo-cosmetics with our international brand leader “Eau Thermale Avène”.

For more than 30 years, Canfield Scientific has been the global leader in the design, development and distribution of imaging and photographic systems, services and products for the medical and aesthetic dermatology markets.  Our specialized imaging software and photographic systems enable image-based consultations for clinical and aesthetic dermatology, plastic surgery and retail skin care. Canfield’s advanced photographic imaging solutions and tools improve communications, align doctor-patient expectations, facilitate treatment planning, and highlight results. Used in medical and aesthetic practices, hospitals, skin care and wellness centers, spas and medical spas, thousands of surgical and non-surgical consultations begin with images captured by Canfield. 

3Gen, Inc. manufactures the DermLite brand of skin imaging devices.

FotoFinder is setting the pace in skin imaging worldwide with leading technology “Made in Germany”.


The bodystudio ATBM is the world leading system for polarized and non-polarized Automated Total Body Mapping, which you can also use for Guided Photo Documentation in aesthetics. The camera FotoFinder medicam 1000 offers the sharpest images in video dermoscopy, trichoscopy, capillaroscopy and inflammoscopy. Her little sister leviacam stands for ultralight brilliance in the most compact camera.


A world innovation is the Moleanalyzer pro software that provides comprehensive support in the assessment of melanocytic and non-melanocytic lesions, allowing risk evaluation via computer scoring aided by Artificial Intelligence (AI).


Further innovations are PASIvision for psoriasis monitoring and computerized PASI assessment as well as Trichovision for trichoscopy, hair analysis and diagnostic support via the TrichoLAB service. Discover also eDermoscopy with the latest handyscope and the FotoFinder and TrichoLAB services for clinical studies. 

To improve patient’s Quality of Life developing and producing, from own original projects, innovative, effective and safe therapeutic systems for clinical practice.


This is our Mission.


At IGEA, we study the clinical application of physical stimuli to biological systems.


Our main areas of interest are:



IGEA therapies, to improve bone healing and joint preservation.



Electrochemotherapy, to treat cancers.


Cells electroporation associated with low doses of anticancer drugs for a safe eradication of tumors.


Electrochemotherapy is a minimally invasive treatment combining a low dose of a chemotherapy drug and an electrical pulse (electroporation) applied directly to the cancer cells using specific multiple needle or individual needle electrodes.


Cliniporator® e Cliniporator® VITAE are the most advanced electroporation technologies for the treatment of tumor nodules located to the skin, subcutaneous tissue, parenchyma and bone.

MAVIG GmbH, a family owned and operated company founded in 1921 and headquartered in Munich, is a quality and innovation leader in the field of X-ray protection. Lucid, Inc., operating as Caliber Imaging & Diagnostics Inc., based in Rochester, New York (USA), is manufacturer of the VivaScope products. In 2006 MAVIG assumed the confocal laser technology distribution rights for Europe, Russia, the Middle East, and North Africa. Both companies work hand in hand concerning R&D in the field of laser scanning microscopy.

SPECLIPSE, INC. has developed a transformative, patented technology for real-time, non-invasive, in vivo cancer diagnosis utilizing laser spectroscopy and machining learning algorithms. Speclipse’s core diagnostic technology is available in two models.  Spectra-Scope® is an “add-on module” which can be attached to existing aesthetic lasers at dermatology or primary care clinics to provide instant skin cancer diagnosis. The second diagnostic model offered is a “stand-alone” system which can be used without any additional equipment or accessories. It can be used by medical or cosmetic clinics who do not have existing laser equipment, or who prefer a small, portable stand-alone device for real-time diagnosis.

Due to the instantaneous nature and high-accuracy results provided by this technology, it is valuable for use in pathology labs for diagnosing biopsy samples, and beneficial for real-time diagnosis during oncological surgeries as well. Spectra-Scope® provides high diagnostic accuracy and real-time results, with a cost-effective and minimal footprint.

Sun Pharma is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company. It provides high-quality, affordable medicines trusted by customers and patients in over 150 countries across the world. Sun Pharma's global presence is supported by 42 manufacturing facilities spread across 6 continents, R&D centers across the globe and a multi-cultural workforce comprising over 50 nationalities. In India, the company enjoys leadership across 11 different classes of doctors with 30 brands featuring amongst top 300 pharmaceutical brands in India. Its footprint across emerging markets covers over 100 markets and 6 markets in Western Europe. Its Global Consumer Healthcare business is ranked amongst Top 10 across 3 global markets. Its API business footprint is strengthened through 14 world class API manufacturing facilities across the globe. Sun Pharma fosters excellence through innovation supported by strong R&D capabilities comprising about 2,000 scientists and R&D investments of approximately 8% of annual revenues.

Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers.


SBC servicios básicos de congresos
Mont-Roig, 13 Atc 2a
08006 Barcelona
Tel. +34 933685538
Fax +34 933685829